Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma

Christian Winther Eskelund; Alexandra Albertsson-Lindblad; Arne Kolstad; Anna Laurell; Riikka Räty; Lone Bredo Pedersen; Christian Hartmann Geisler; Mats Jerkeman; Kirsten Grønbæk

doi:10.3324/haematol.2018.194399

Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma

Christian Winther Eskelund, Alexandra Albertsson-Lindblad, Arne Kolstad, Anna Laurell, Riikka Räty, Lone Bredo Pedersen, Christian Hartmann Geisler, Mats Jerkeman, Kirsten Grønbæk

19 Citations (Scopus)

Original language	English
Journal	Haematologica
Volume	3
Issue number	11
Pages (from-to)	541-543
Number of pages	3
ISSN	0390-6078
DOIs	https://doi.org/10.3324/haematol.2018.194399
Publication status	Published - Nov 2018

Access to Document

10.3324/haematol.2018.194399

Cite this

@article{d20c45b2f2c943bb9c5dcf809d18b2e0,

title = "Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma",

author = "Eskelund, \{Christian Winther\} and Alexandra Albertsson-Lindblad and Arne Kolstad and Anna Laurell and Riikka R{\"a}ty and Pedersen, \{Lone Bredo\} and Geisler, \{Christian Hartmann\} and Mats Jerkeman and Kirsten Gr{\o}nb{\ae}k",

year = "2018",

month = nov,

doi = "10.3324/haematol.2018.194399",

language = "English",

volume = "3",

pages = "541--543",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "11",

}

TY - JOUR

T1 - Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma

AU - Eskelund, Christian Winther

AU - Albertsson-Lindblad, Alexandra

AU - Kolstad, Arne

AU - Laurell, Anna

AU - Räty, Riikka

AU - Pedersen, Lone Bredo

AU - Geisler, Christian Hartmann

AU - Jerkeman, Mats

AU - Grønbæk, Kirsten

PY - 2018/11

Y1 - 2018/11

UR - https://www.scopus.com/pages/publications/85055771868

U2 - 10.3324/haematol.2018.194399

DO - 10.3324/haematol.2018.194399

M3 - Journal article

C2 - 29794145

SN - 0390-6078

VL - 3

SP - 541

EP - 543

JO - Haematologica

JF - Haematologica

IS - 11

ER -

Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma

Access to Document

Other files and links

Cite this